{"result": "(\"entity\"<|>ENFERMEDAD INFLAMATORIA INTESTINAL<|>EVENT<|>A medical condition that includes colitis ulcerosa and enfermedad de Crohn, which can lead to severe malnutrition.)\n##\n(\"entity\"<|>CAQUEXIA CANCEROSA<|>EVENT<|>A condition characterized by severe weight loss and muscle wasting due to chronic illness, often seen in cancer patients.)\n##\n(\"entity\"<|>PATOLOGÍA MÉDICA INFECCIOSA<|>EVENT<|>A medical condition involving severe malabsorption due to infectious diseases, such as AIDS.)\n##\n(\"entity\"<|>FIBROSIS QUÍSTICA<|>EVENT<|>A genetic disorder that affects the lungs and digestive system, leading to malnutrition and other complications.)\n##\n(\"entity\"<|>FÍSTULAS ENTEROCUTÁNEAS<|>EVENT<|>Abnormal connections between the intestine and skin that can lead to severe malnutrition.)\n##\n(\"entity\"<|>INSUFICIENCIA RENAL INFANTIL<|>EVENT<|>A condition in children where the kidneys fail to function properly, affecting growth and nutrition.)\n##\n(\"relationship\"<|>ENFERMEDAD INFLAMATORIA INTESTINAL<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Patients with inflammatory bowel disease may require home nutritional treatment due to malnutrition.<|>7)\n##\n(\"relationship\"<|>CAQUEXIA CANCEROSA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Patients suffering from cancer cachexia may need home nutritional treatment to manage their condition.<|>7)\n##\n(\"relationship\"<|>PATOLOGÍA MÉDICA INFECCIOSA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Patients with severe infectious diseases may require home nutritional treatment due to malabsorption issues.<|>7)\n##\n(\"relationship\"<|>FIBROSIS QUÍSTICA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Patients with cystic fibrosis often need home nutritional treatment to address malnutrition.<|>7)\n##\n(\"relationship\"<|>FÍSTULAS ENTEROCUTÁNEAS<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Patients with enterocutaneous fistulas may require home nutritional treatment due to nutrient loss.<|>7)\n##\n(\"relationship\"<|>INSUFICIENCIA RENAL INFANTIL<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Children with renal failure may need home nutritional treatment to support their growth and health.<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: o intolerancia diagnosticada a las proteínas de leche de vaca en lactantes, hasta dos años si existe\n    compromiso nutricional\nC.4 Pacientes desnutridos que van a ser sometidos a cirugía mayor programada o trasplantes\nC.5 Pacientes con encefalopatía hepática crónica con intolerancia a las proteínas de la dieta\nC.6 Pacientes con adrenoleucodistrofia ligada al cromosoma X, neurológicamente asintomáticos\n\n### D. Situaciones clínicas cuando cursan con desnutrición severa\n\nD.1 Enfermedad inflamatoria intestinal: colitis ulcerosa y enfermedad de Crohn\nD.2 Caquexia cancerosa por enteritis crónica por tratamiento quimio y/o radioterápico\nD.3 Patología médica infecciosa que comporta malabsorción severa: sida\nD.4 Fibrosis quística\nD.5 Fístulas enterocutáneas de bajo débito\nD.6 Insuficiencia renal infantil que compromete el crecimiento del paciente\n---\n## BLOQUE: NUTRICIÓN Y ASPECTOS LEGALES\n\n### Tabla 3. Requerimientos para nutrición domiciliaria según comunidades autónomas.\n\n| Ámbito | Documentación | Lugar al que debe dirigirse para continuar el tratamiento |\n|--------|---------------|----------------------------------------------------------|\n| Andalucía | Informe justificativo de la indicación | Médico de atención primaria<br>DISPENSACIÓN: Oficinas de farmacia |\n| Aragón | Informe justificativo de la indicación (especialista hospitalario) | Médico de atención primaria<br>DISPENSACIÓN: Oficinas de farmacia |\n| Asturias | Informe justificativo de la indicación | Médico de atención primaria<br>DISPENSACIÓN: Oficinas de farmacia |\n| Baleares | Informe justificativo de la indicación (especialista hospitalario) | Médico de atención primaria<br>DISPENSACIÓN: Oficinas de farmacia |\n| Canarias | Informe justificativo de la indicación | Servicio de Atención al Paciente de los hospitales de Servicio Canario de Salud |\n| Cantabria | Informe justificativo de la indicación | Médico de atención primaria<br>DISPENSACIÓN: Oficinas de farmacia |\n| Castilla y León | Informe justificativo de la indicación (especialista hospitalario) | Médico de atención primaria<br>DISPENSACIÓN: Oficinas de farmacia |\n| Castilla-La Mancha | Informe justificativo de la indicación (especialista) | Médico de atención primaria<br>DISPENSACIÓN: Oficinas de farmacia |\n| Cataluña | Informe justificativo de la indicación | Centro de atención primaria que le corresponda según su lugar de residencia en Cataluña<br>DISPENSACIÓN: Oficinas de farmacia |\n| Comunidad Valenciana | Informe justificativo de la indicación | Médico de atención primaria<br>DISPENSACIÓN: Oficinas de farmacia |\n| Extremadura | Informe justificativo de la indicación | Médico de atención primaria<br>DISPENSACIÓN: Oficinas de farmacia |\n| Galicia | Informe justificativo de la indicación | Subdirección General de Farmacia y Productos Sanitarios. Teléfonos: 981542846/981540149. C/ San Lázaro s/n. Edificio administrativo del Servicio Gallego de Salud. 15703. Santiago de Compostela.<br>DISPENSACIÓN: Hospitales de la red del SERGAS. |\n| La Rioja | Informe justificativo de la indicación | Inspección de Servicios Sanitarios que le corresponda por domicilio (Calahorra o Logroño).<br>DISPENSACIÓN: Oficinas de farmacia. |\n| Madrid | Informe justificativo de la indicación | Centro de atención primaria más próximo a su domicilio.<br>DISPENSACIÓN: Oficinas de farmacia. |\n| Murcia | Informe justificativo de la indicación | Médico de atención primaria.<br>DISPENSACIÓN: Oficinas de farmacia. |\n| Navarra | Informe justificativo de la indicación | Médico de atención primaria.<br>DISPENSACIÓN: Oficinas de farmacia. |\n| País Vasco | Informe justificativo de la indicación | Inspección de Servicios Sanitarios más próxima al domicilio temporal del paciente.<br>DISPENSACIÓN: Oficinas de farmacia. |\n| Ingesa | Informe justificativo de la indicación | Médico de atención primaria.<br>DISPENSACIÓN: Oficinas de farmacia. |\n---\nTema 60. Nutrición artificial domiciliaria 941\n\n## 1.2. Regulación de la NPD en España\n\nLa NP está incluida en la cartera de prestaciones del SNS (RD 1030/2006), tanto en el medio hospitalario como extrahospitalario, pero a diferencia de la NED no se dispone de una legislación específica que indique cómo debe\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ANDALUCÍA<|>GEO<|>Andalucía is an autonomous community in Spain where patients must provide a justification report for nutritional treatment to their primary care physician.)\n##\n(\"entity\"<|>ARAGÓN<|>GEO<|>Aragón is an autonomous community in Spain where patients need a justification report from a hospital specialist for nutritional treatment.)\n##\n(\"entity\"<|>ASTURIAS<|>GEO<|>Asturias is an autonomous community in Spain where patients must submit a justification report for nutritional treatment to their primary care physician.)\n##\n(\"entity\"<|>BALEARES<|>GEO<|>Baleares is an autonomous community in Spain requiring a justification report from a hospital specialist for nutritional treatment.)\n##\n(\"entity\"<|>CANARIAS<|>GEO<|>Canarias is an autonomous community in Spain where patients must contact the Patient Care Service of the hospitals for nutritional treatment.)\n##\n(\"entity\"<|>CANTABRIA<|>GEO<|>Cantabria is an autonomous community in Spain where patients need to provide a justification report for nutritional treatment to their primary care physician.)\n##\n(\"entity\"<|>CASTILLA Y LEÓN<|>GEO<|>Castilla y León is an autonomous community in Spain where a justification report from a hospital specialist is required for nutritional treatment.)\n##\n(\"entity\"<|>CASTILLA-LA MANCHA<|>GEO<|>Castilla-La Mancha is an autonomous community in Spain where a justification report from a specialist is needed for nutritional treatment.)\n##\n(\"entity\"<|>CATALUÑA<|>GEO<|>Cataluña is an autonomous community in Spain where patients must submit a justification report for nutritional treatment to their corresponding primary care center.)\n##\n(\"entity\"<|>COMUNIDAD VALENCIANA<|>GEO<|>Comunidad Valenciana is an autonomous community in Spain where patients need to provide a justification report for nutritional treatment to their primary care physician.)\n##\n(\"entity\"<|>EXTREMADURA<|>GEO<|>Extremadura is an autonomous community in Spain where patients must submit a justification report for nutritional treatment to their primary care physician.)\n##\n(\"entity\"<|>GALICIA<|>GEO<|>Galicia is an autonomous community in Spain where patients must submit a justification report for nutritional treatment to the General Directorate of Pharmacy and Health Products.)\n##\n(\"entity\"<|>LA RIOJA<|>GEO<|>La Rioja is an autonomous community in Spain where patients need to provide a justification report for nutritional treatment to the corresponding Health Services Inspection.)\n##\n(\"entity\"<|>MADRID<|>GEO<|>Madrid is an autonomous community in Spain where patients must submit a justification report for nutritional treatment to the nearest primary care center.)\n##\n(\"entity\"<|>MURCIA<|>GEO<|>Murcia is an autonomous community in Spain where patients need to provide a justification report for nutritional treatment to their primary care physician.)\n##\n(\"entity\"<|>NAVARRA<|>GEO<|>Navarra is an autonomous community in Spain where patients must submit a justification report for nutritional treatment to their primary care physician.)\n##\n(\"entity\"<|>PAÍS VASCO<|>GEO<|>País Vasco is an autonomous community in Spain where patients need to provide a justification report for nutritional treatment to the nearest Health Services Inspection.)\n##\n(\"entity\"<|>INGESA<|>GEO<|>INGESA is an organization in Spain where patients must submit a justification report for nutritional treatment to their primary care physician.)\n##\n(\"entity\"<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>EVENT<|>Nutritional treatment provided at home, regulated under Spanish law for patients requiring special dietary needs.)\n##\n(\"relationship\"<|>ANDALUCÍA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Andalucía, patients must provide a justification report to continue nutritional treatment at home.<|>5)\n##\n(\"relationship\"<|>ARAGÓN<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Aragón, patients need a justification report from a hospital specialist for home nutritional treatment.<|>5)\n##\n(\"relationship\"<|>ASTURIAS<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Asturias, patients must submit a justification report for home nutritional treatment.<|>5)\n##\n(\"relationship\"<|>BALEARES<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Baleares, a justification report from a hospital specialist is required for home nutritional treatment.<|>5)\n##\n(\"relationship\"<|>CANARIAS<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Canarias, patients must contact the Patient Care Service for home nutritional treatment.<|>5)\n##\n(\"relationship\"<|>CANTABRIA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Cantabria, patients need to provide a justification report for home nutritional treatment.<|>5)\n##\n(\"relationship\"<|>CASTILLA Y LEÓN<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Castilla y León, a justification report from a hospital specialist is required for home nutritional treatment.<|>5)\n##\n(\"relationship\"<|>CASTILLA-LA MANCHA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Castilla-La Mancha, a justification report from a specialist is needed for home nutritional treatment.<|>5)\n##\n(\"relationship\"<|>CATALUÑA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Cataluña, patients must submit a justification report for home nutritional treatment to their primary care center.<|>5)\n##\n(\"relationship\"<|>COMUNIDAD VALENCIANA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Comunidad Valenciana, patients need to provide a justification report for home nutritional treatment.<|>5)\n##\n(\"relationship\"<|>EXTREMADURA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Extremadura, patients must submit a justification report for home nutritional treatment.<|>5)\n##\n(\"relationship\"<|>GALICIA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Galicia, patients must submit a justification report for home nutritional treatment to the General Directorate of Pharmacy.<|>5)\n##\n(\"relationship\"<|>LA RIOJA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In La Rioja, patients need to provide a justification report for home nutritional treatment.<|>5)\n##\n(\"relationship\"<|>MADRID<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Madrid, patients must submit a justification report for home nutritional treatment to the nearest primary care center.<|>5)\n##\n(\"relationship\"<|>MURCIA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Murcia, patients need to provide a justification report for home nutritional treatment.<|>5)\n##\n(\"relationship\"<|>NAVARRA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In Navarra, patients must submit a justification report for home nutritional treatment.<|>5)\n##\n(\"relationship\"<|>PAÍS VASCO<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In País Vasco, patients need to provide a justification report for home nutritional treatment.<|>5)\n##\n(\"relationship\"<|>INGESA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>In INGESA, patients must submit a justification report for home nutritional treatment.<|>5)\n<|COMPLETE|>"}]}